相关实验视频

Updated: Jul 26, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K

成本效益分析和扩展治疗准入模型对转换到从约旦的参考Rituximab转换到Rituximab生物类似药的成本效益分析和扩展治疗准入模型

Hala H Halawah1, Nimer S Alkhatib1,2,3, Abdulaali R Almutairi4

  • 1Al-Zaytoonah University of Jordan, Amman, Jordan.

Journal of medical economics
|June 15, 2023
PubMed
概括

利图西马布生物仿制药在约旦提供了显著的成本节约和改善了患者的获取. 里克萨顿证明了每名患者最低的成本和最高的访问扩展,这使得它成为一个非常具有成本效益的选择.

关键词:
生物类似药物 生物类似药物在这里,我们可以看到H H H H H H.H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H5 H3 H5 H5 H5 H5 H3 H4 H5 H5 H6 H7 H8 H8 H8 H8 H8 H8 H8 H9 在线阅读更多H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51 H51我已经开始了,我已经开始了.第111章 这是什么?第115章 在这里约旦 约旦 约旦 约旦经济效率 经济效率 经济效率扩大了访问权限的扩大这就是Rituximab.

更多相关视频

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.6K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

14.9K

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Bioequivalence: Overview01:16

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
109
Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
187